FDA Drugs (New Approvals & NDA)Original article
Public Meeting on the Recommendations for Reauthorization of the Prescription Drug User Fee Act (PDUFA) - 09/16/2026
RegulatoryNeutral
AI Analysis
Summary
The FDA is announcing a public meeting scheduled for September 16, 2026, to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years 2028 through 2032.
Importance:2/10
Sentiment:
0.00
PDUFAFDARegulatoryPublic MeetingReauthorization
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 1, 2026 1:38 PM